In August 2022, KSL Beutner Laboratories (Beutner) introduced a blood test designed to identify an antigen associated with the autoimmune blistering condition known as mucous membrane pemphigoid (MMP) ...

Fibrosis is an important component of the inflammatory response. In many diseases including proliferative vitreoretinopathy, mucous membrane pemphigoid, cirrhosis, scleroderma, idiopathic pulmonary ...

Perspectives of Lymphoma Survivors and Oncology Care Providers on Survivorship Care: A Qualitative Study Immune checkpoint inhibitors (ICIs) have revolutionized cancer treatment, offering new hope ...

Sanofi and Regeneron’s blockbuster biologic Dupixent (dupilumab) is poised for yet another label expansion, this time for the rare autoimmune skin disorder bullous pemphigoid (BP). The US Food ...

As Sanofi and Regeneron await the FDA decision, a legal dispute between the partners over commercialisation details continues ...

Consult your pharmacist or physician. In the US - Call your doctor for medical advice about side effects. You may report side effects to FDA at 1-800-FDA-1088 or at ...

Autoimmune bullous diseases are often associated with significant morbidity and some can even cause mortality, if left untreated. Multiple therapies are now available to treat these blistering ...

Dermatologists often evaluate and treat conditions involving the mucous membranes. This epithelium is present not only in the eye, mouth, and genitalia but also in the nasopharynx. Although ...

Pemphigoid diseases are a subgroup of autoimmune skin diseases characterized by widespread tense blisters. Standard of care typically involves immunosuppressive treatments, which may be insufficient ...